Our digital patient companionoffers a cost-effective and scalable tool to remotely engagepatients in clinical trials.
70% of potential participants live over 2 hours away from trial sites¹, while the average willingness to travel is less than 30 minutes².
Our digital companionsintegrated in everyday devices help to reach more patients at scale, anywhere and anytime.
Systematic data for clinical trials show 24% patients are non-adherent and 12% suboptimal adherent.
Our digital companions motivate with empathic and personalized interactions to comply better and stay longer on trial.
Adequate number of participants and study center visits are the largest single factors driving study costs.
Our patient apps collect data directly from patients, bypassing costly study center visits. They increase engagement reducing the risk of dropouts.
?100 percent of pharma companies and CROs expect virtual trials to be a major component of their portfolio, 89 percent expect to run a trial with most activities conducted in participants? homes.?
(McKinsey study 2021)